Phase I trial of ChronVac-C [hepatitis C DNA vaccine] in combination with TG-4040 in treatment-naive patients with hepatitis C.

Next Previous
Trial Profile

Phase I trial of ChronVac-C [hepatitis C DNA vaccine] in combination with TG-4040 in treatment-naive patients with hepatitis C.

Planning
Phase of Trial: Phase I

Latest Information Update: 10 Oct 2011

At a glance

  • Drugs Hepatitis C DNA vaccine; TG 4040
  • Indications Hepatitis C
  • Focus Pharmacodynamics

    • Most Recent Events

    • 10 Oct 2011 Planned initiation date changed to 1 December 2011, according to Inovio media release.
    • 20 Apr 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top